Acer Therapeutics Inc. (ACER) Accused of Misleading Investors According to the filed complaint for alleged violations of the Securities Exchange Act of 1934 between September 25, 2017 and June 24,
CPI Aerostructures, Inc. (CVU) Discovers Material Weakness in Its Financial Reporting On February 7, 2019, CPI Aerostructures, Inc. (CVU)’s Audit Committee determined that the company’s previously issued financial statements should
Robbins LLP is Investigating Greenlane Holdings, Inc. (GNLN) Greenlane Holdings, Inc. (GNLN) is being investigated for potential violations of federal securities laws pursuant to the company’s April 2019 initial public
Impinj, Inc. (PI) Accused of Misleading Investors Regarding Product Demand According to the filed complaint against the company’s officers and directors for breaches of their fiduciary duty, unjust enrichment, and
Robbins LLP is Investigating Dropbox, Inc. (DBX) Robbins LLP informs shareholders that it is investigating Dropbox, Inc. (NASDAQ: DBX) for potential violations of federal securities laws pursuant to its March
The FDA Requested Allergan Recall all Breast Implants and Tissue Expanders from the Market to Protect Patients The Food and Drug Administration (“FDA”) has requested that Allergan recall all BIOCELL
American Renal Associates Holdings, Inc. (ARA) Accused of Improper Revenue Recognition According to the filed class action complaint against the company for alleged violations of the Securities Exchange Act of
Textron Inc. (TXT) Accused of Misleading Shareholders According to the filed complaint for alleged violations of the Securities Exchange Act of 1934 between January 31, 2018 and October 17, 2018,
Terex Corporation (TEX) Derrer v. Defeo, et al., Case No. 3:10-cv-00550-RNC (D. Conn.) Stipulation and Agreement of Settlement Notice of Pendency of Derivative Action, Proposed Settlement of Derivative Action, Settlement
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Protect yourStock Watch members receive free investment monitoring and notifications.
